Beyond Antioxidants: Phytochemicals in Cardiometabolic Disease Through the Gut Microbiota-Epigenetic-Senescence-Inflammasome Axis

Cardiometabolic diseases, including obesity, type 2 diabetes mellitus (T2DM), metabolic dysfunction-associated steatotic liver disease (MASLD), and cardiovascular diseases (CVDs), represent a major global health burden. Their pathogenesis involves interconnected processes, including oxidative stress, chronic inflammation, gut microbiota dysbiosis, epigenetic alterations, and cellular senescence. Phytochemicals, naturally occurring bioactive compounds found in plant-derived foods, have traditionally been studied for their antioxidant properties. However, emerging evidence suggests that their effects extend beyond free-radical scavenging and involve the modulation of interconnected molecular pathways. This review explores the potential role of phytochemicals in cardiometabolic health, focusing on the gut microbiota- epigenetics- senescence- inflammasome axis. Phytochemicals interact bidirectionally with the gut microbiota, influencing microbial composition, intestinal barrier integrity, and the production of bioactive metabolites, including short-chain fatty acids. These interactions may affect epigenetic regulation, inflammatory signaling, and cellular senescence. Particular attention is given to the senescence-associated secretory phenotype and its interplay with inflammasome activation, especially the NLRP3 inflammasome, which may contribute to chronic inflammation and metabolic dysfunction. Nevertheless, clinical translation remains challenging because of differences in bioavailability, interindividual variability in gut microbiota composition, and the predominance of preclinical evidence for several proposed mechanisms. Understanding these interactions may help identify novel preventive and therapeutic strategies for cardiometabolic diseases and guide future research toward targeted, microbiota-informed nutritional interventions.

Authors

Publication Details

Journal
Preprints.org
Published
2026-11-17
DOI
https://doi.org/10.20944/preprints202611.1618.v1
Primary Topic
Gut microbiota and health
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Beyond Antioxidants: Phytochemicals in Cardiometabolic Disease Through the Gut Microbiota-Epigenetic-Senescence-Inflammasome Axis

Przemysław Zalewski, Judyta Cielecka‐Piontek, Michał Karpiński, Katarzyna Zalewska et al.
2 links
Preprints.org
Gut microbiota and health
preprint

Beyond Antioxidants: Phytochemicals in Cardiometabolic Disease Through the Gut Microbiota-Epigenetic-Senescence-Inflammasome Axis

Przemysław Zalewski, Judyta Cielecka‐Piontek, Michał Karpiński, Katarzyna Zalewska, Maciej Kulawik, Ewelina Swora-Cwynar, Zofia Szymańska, Antoni Staniewski, Oliwia Kalus, Zofia Gramala, Joanna Maćkowiak, Barbara Zalewska, Julia Gierszewska, Dominik Dykcik, Wei Lu
preprint en

Abstract

Cardiometabolic diseases, including obesity, type 2 diabetes mellitus (T2DM), metabolic dysfunction-associated steatotic liver disease (MASLD), and cardiovascular diseases (CVDs), represent a major global health burden. Their pathogenesis involves interconnected processes, including oxidative stress, chronic inflammation, gut microbiota dysbiosis, epigenetic alterations, and cellular senescence. Phytochemicals, naturally occurring bioactive compounds found in plant-derived foods, have traditionally been studied for their antioxidant properties. However, emerging evidence suggests that their effects extend beyond free-radical scavenging and involve the modulation of interconnected molecular pathways. This review explores the potential role of phytochemicals in cardiometabolic health, focusing on the gut microbiota- epigenetics- senescence- inflammasome axis. Phytochemicals interact bidirectionally with the gut microbiota, influencing microbial composition, intestinal barrier integrity, and the production of bioactive metabolites, including short-chain fatty acids. These interactions may affect epigenetic regulation, inflammatory signaling, and cellular senescence. Particular attention is given to the senescence-associated secretory phenotype and its interplay with inflammasome activation, especially the NLRP3 inflammasome, which may contribute to chronic inflammation and metabolic dysfunction. Nevertheless, clinical translation remains challenging because of differences in bioavailability, interindividual variability in gut microbiota composition, and the predominance of preclinical evidence for several proposed mechanisms. Understanding these interactions may help identify novel preventive and therapeutic strategies for cardiometabolic diseases and guide future research toward targeted, microbiota-informed nutritional interventions.

Preprints.org
Good health and well-being
Gut microbiota and health
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon